Correspondence 0001193125-22-284558 from Annexon, Inc. (ANNX) (CIK 0001528115) (ANNX)
Annexon, Inc. (ANNX) (CIK 0001528115)
Date: Nov. 14, 2022 · CIK: 0001528115 · Accession: 0001193125-22-284558
AI Filing Summary & Sentiment
File numbers found in text: 333-268181
Show Raw Text
CORRESP 1 filename1.htm CORRESP Annexon, Inc. 1400 Sierra Point Parkway, Bldg C, Suite 200 Brisbane, California 94005 November 14, 2022 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Annexon, Inc. Registration Statement on Form S-3 Filed November 4, 2022 Registration No. 333-268181 To whom it may concern: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Annexon, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated by the Securities and Exchange Commission to 4:00 p.m. Washington D.C. time on November 16, 2022, or as soon as practicable thereafter, or at such later time as the Company or its counsel may request via telephone call to the staff. Please contact Kathleen M. Wells of Latham & Watkins LLP, counsel to the Company, at (650) 463-2677, or in her absence, Richard Kim of Latham & Watkins LLP at (650) 470-4980, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter. Thank you for your assistance in this matter. * * * * Sincerely, Annexon, Inc. By: /s/ Jennifer Lew Jennifer Lew Chief Financial Officer and Secretary cc: Douglas Love, Esq., Annexon, Inc. Kathleen M. Wells, Latham & Watkins LLP Brian J. Cuneo, Latham & Watkins LLP Richard Kim, Latham & Watkins LLP